Skip to content

HelloBetter Chronic Pain Study

HelloBetter Chronic Pain Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027176
Enrollment
360
Registered
2022-01-12
Start date
2022-01-21
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M79.7 M54 F45.40 F45.41 R52.1 R52.2

Interventions

Group 1: The intervention group receives direct access to the online programme HelloBetter ratiopharm chronic pain. The programme consists of 7 units and aims to reduce pain interference. Pain interfe

Sponsors

GET.ON Institut für Online Gesundheitstrainings GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic pain (duration = 3 months), At least substantial pain disability (at least severity level 1 according to Korff's pain disability scale), Age = 18 years, Sufficient knowledge of German, Sufficient computer and internet skills, Internet access

Exclusion criteria

Exclusion criteria: Tumour-related pain, Substantial suicide risk at baseline measured by item 9 of the BDI II (value >1)

Design outcomes

Primary

MeasureTime frame
Pain interference measured by the West Haven-Yale Multidimensional Pain Inventory (MPI) interference scale post-treatment (3 months).

Secondary

MeasureTime frame
- Emotional functioning (Patient Health Questionnaire 9 Item Version, PHQ-9), pre, post (3 months), 6- and 12-months follow-up - Health-related quality of life (Assessment of Quality of Life, AQOL-8D), pre, post (3 months), 6- and 12-months follow-up - Pain (intensity and interference, Brief Pain Inventory, BPI), pre, post (3 months), 6- and 12-months follow-up - Multidimensional pain interference: Pain intensity, self-control, negative mood (West Haven-Yale Multidimensional Pain Inventory (MPI), baseline, post (3 months), 6- and 12-months follow-up - Pain impairment in everday life (Pain Disability Index, PDI), baseline, post (3 months), 6- and 12-months follow-up - Anxiety (Generalised Anxiety Disorder Scale-7, GAD-7), baseline, post (3 months), 6- and 12-months follow-up - Pain processing (Fragebogen zur Erfassung der Schmerzverarbeitung, FESV), baseline, post (3 months), 6- and 12-months follow-up - Pain acceptance (Chronic Pain Acceptance Questionnaire, CPAQ), baseline, post (3 months), 6- and 12-months follow-up - Psychological flexibility (Acceptance and Action Questionnaire II, FAH-II; Psychological Inflexibility in Pain Scale, PIPS), baseline, post (3 months), 6- and 12-months follow-up - Pain-specific self efficacy (Pain Self-Efficacy Questionnaire, PSEQ), baseline, post (3 months), 6- and 12-months follow-up - Patient satisfaction questionnaire (CSQ-8), post (IG only) - Negative effects questionnaire (NEQ), post (IG only) - Subjective global assessment of change (PGIC), post

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026